Fuda Cancer Institute

Fuda Cancer Institute, primarily known as Guangzhou Fuda Cancer Hospital, is a specialized oncology facility located in Guangzhou, China, renowned for its focus on minimally invasive cancer treatments. The institute is a global leader in cryosurgery (cryoablation) and Irreversible Electroporation (NanoKnife) for advanced-stage solid tumors. It integrates high-tech medical interventions with personalized immunotherapy and traditional treatments to manage complex cases, particularly for patients with unresectable cancers. Fuda is recognized as a National Key Clinical Specialty in Oncology and serves a significant international patient base from over 100 countries. The hospital operates under a unique 3C+P treatment model, combining cryosurgery, microvascular intervention, and combined immunotherapy.